Sort
40,608 grants matching “prostate cancer”
Immune activation by necroptotic cell death
$424,373Andrew Atwell Oberst · University Of Washington · R01 · FY2021 · CA
Targeted MRI contrast agents for differential diagnosis of prostate cancer
$424,315Zheng-Rong Lu · Case Western Reserve University · R01 · FY2018 · CA
PRISTINE: Pre-cancer histology identification of Endobronchial biopsies using deep learning
$424,256Jennifer Ellen Beane · Boston University Medical Campus · R21 · FY2020 · CA
Leveraging deep learning for markerless motion management in radiation therapy
$424,249Lei Xing · Stanford University · R01 · FY2023 · CA
Anti-Tumor Mechanisms and Therapeutic Effects of Vitamin D
$424,249Candace S Johnson · Roswell Park Cancer Institute Corp · R01 · FY2011 · CA
Leveraging deep learning for markerless motion management in radiation therapy
$424,249Lei Xing · Stanford University · R01 · FY2022 · CA
Genetic Mechanisms Controlling Kidney Cancer Immune Escape
$424,094Haydn Kissick · Emory University · R01 · FY2024 · CA
Novel Pathways in the Control of Lineage Plasticity in Neuroendocrine Prostate Cancer
$424,047Maria Teresa Diaz Meco Conde · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA
Novel Pathways in the Control of Lineage Plasticity in Neuroendocrine Prostate Cancer
$424,047Maria Teresa Diaz Meco Conde · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
Project 2: Integrating a Novel MiPS-Based Next-Generation Sequencing Urine Assay for the Early Detection of Unfavorable Risk Prostate Cancer
$423,860Ganesh S Palapattu · University Of Michigan At Ann Arbor · P50 · FY2019 · CA
Functional Determinants of Metastatic Dormancy
$423,844Julio A Aguirre-Ghiso · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · CA
Functional Determinants of Metastatic Dormancy
$423,844Julio A Aguirre-Ghiso · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · CA
Statewide Communication to Reach Diverse Low Income Women
$423,805Rena Joy Pasick · University Of California, San Francisco · R01 · FY2010 · CA
The role of Tmeff2 in prostate cancer development
$423,803Maria Jesus Ruiz Echevarria · East Carolina University · R15 · FY2011 · CA
Transmembrane Proteins Involved in Human Tumor Expansion
$423,800James P Quigley · Scripps Research Institute, The · R01 · FY2018 · CA
Genetic Epidemiology of Prostate Cancer
$423,798Janet L Stanford · Fred Hutchinson Cancer Research Center · R01 · FY2008 · CA
HIFU-enhanced tumor vaccines
$423,775Chandan Guha · Albert Einstein College Of Medicine · R01 · FY2009 · EB
Cell Growth Signaling in Cancer Development
$423,772David M Sabatini · Whitehead Institute For Biomedical Res · R01 · FY2010 · CA
Dissecting the influence of DNA damage response and homologous recombination deficiencies on tumor immunogenicity
$423,750Robert M Samstein · Icahn School Of Medicine At Mount Sinai · DP5 · FY2022 · OD
Dissecting the influence of DNA damage response and homologous recombination deficiencies on tumor immunogenicity
$423,750Robert M Samstein · Icahn School Of Medicine At Mount Sinai · DP5 · FY2023 · OD
Dissecting the influence of DNA damage response and homologous recombination deficiencies on tumor immunogenicity
$423,750Robert M Samstein · Icahn School Of Medicine At Mount Sinai · DP5 · FY2019 · OD
Dissecting the influence of DNA damage response and homologous recombination deficiencies on tumor immunogenicity
$423,750Robert M Samstein · Icahn School Of Medicine At Mount Sinai · DP5 · FY2021 · OD
Dissecting the influence of DNA damage response and homologous recombination deficiencies on tumor immunogenicity
$423,750Robert M Samstein · Icahn School Of Medicine At Mount Sinai · DP5 · FY2020 · OD
Novel Therapeutic Strategies to Co-Target Undifferentiated Prostate Cancer (PCa) Stem Cells and Bulk PCa Cells
$423,743Dean G Tang · Roswell Park Cancer Institute Corp · R01 · FY2022 · CA
Serum Antibody Profiling with a Carbohydrate Microarray
$423,701Jeff Gildersleeve · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA